Skip to content

Can I use My FDA Approval in Europe?


7 mins


FDA approval does not automatically allow you to sell medical devices in Europe. The US and European systems operate independently, with different regulatory bodies, approval processes, and legal requirements. To market your device in Europe, you must obtain CE marking through a separate conformity assessment process, regardless of your FDA status. This article addresses the key questions about using US medical device approval in European markets.

Can you use FDA Approval to Sell Medical Devices in Europe?

You cannot use FDA approval alone to sell medical devices in Europe. FDA clearance or approval applies only to the US market and holds no legal authority in the European Union, UK, or Switzerland. European regulators require CE marking, which demonstrates compliance with entirely separate regulations including the Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR).

The systems exist separately because the US and Europe developed distinct regulatory philosophies over decades:

  • FDA centralized review: The FDA operates as a centralized government agency that reviews and approves devices before they reach patients, making market authorization decisions directly
  • European conformity assessment: Europe uses a conformity assessment approach where manufacturers demonstrate compliance with essential requirements, often with assessment from independent Notified Bodies rather than direct government review
  • Manufacturer responsibility: European regulations place greater emphasis on manufacturer self-declaration of conformity, with third-party verification for higher-risk devices

These fundamental differences in regulatory philosophy mean that approval in one jurisdiction doesn’t translate to market access in the other. Your FDA approval shows you’ve met US requirements, but it doesn’t satisfy European legal obligations. You’ll need separate technical documentation, conformity assessments, and registration in European databases. The good news is that much of your existing FDA work can support your European submission, reducing duplication while you address Europe-specific requirements.

What’s the Difference Between FDA Approval and CE Marking for Medical Devices?

FDA approval involves submission to a single government agency that reviews your device and grants market authorization. CE marking requires you to demonstrate conformity with European regulations, often assessed by private Notified Bodies, with the manufacturer declaring conformity rather than receiving government approval.

The key differences between these regulatory systems include:

  • Classification criteria: The FDA classifies devices into Class I, II, or III based primarily on risk, while Europe’s MDR system uses similar risk categories but applies different criteria, meaning your device classification may differ between markets
  • Approval authority: The FDA acts as a gatekeeper making approval decisions, whereas Europe places responsibility on manufacturers to ensure compliance with Notified Bodies verifying conformity assessments
  • Clinical data requirements: FDA Class III devices require premarket approval with extensive clinical data, while European requirements vary based on device classification and novelty, often allowing greater reliance on equivalence and literature reviews
  • Regulatory timelines: FDA review processes follow defined timelines with agency response deadlines, while European conformity assessment timelines depend on Notified Body capacity and the complexity of your technical documentation

Both systems ultimately aim for patient safety, but the path to market access follows different routes with distinct documentation requirements, assessment procedures, and legal frameworks. Understanding these differences helps you plan appropriate resources and timelines for each market.

What do you Actually Need to Enter the European Medical Device Market?

You need CE marking to legally place devices on the European market. This requires comprehensive technical documentation demonstrating compliance with applicable regulations, a quality management system meeting ISO 13485 standards, and clinical evaluation reports showing your device’s safety and performance. Higher-risk devices require Notified Body assessment before you can affix the CE mark.

Your technical documentation must include several essential components:

  • Device description and specifications: Detailed technical information covering intended purpose, design features, materials, and performance characteristics
  • Risk management files: Comprehensive risk analysis following ISO 14971, identifying hazards and demonstrating risk mitigation measures
  • Design verification and validation: Evidence proving your device meets design specifications and user needs in actual use conditions
  • Clinical evaluation reports: Synthesis of available clinical data, including literature reviews and your own clinical investigations, demonstrating safety and performance
  • Labeling and instructions for use: User documentation meeting European standards, including appropriate languages and symbol usage
  • Post-market surveillance plans: Systems for monitoring device performance after market release and reporting incidents to authorities

These documentation requirements form the foundation of your conformity assessment, demonstrating that your device meets all applicable essential requirements. Beyond documentation, you’ll need practical infrastructure to operate in Europe.

You’ll also need an EU Authorized Representative if you’re a manufacturer based outside Europe. This local contact point handles regulatory communications with authorities and must be identified on your device labeling. Registration in EUDAMED, Europe’s medical device database, is required for device tracking and transparency, though full implementation continues in phases. Working with an independent representative who focuses on regulatory affairs rather than sales ensures your compliance obligations receive proper attention without commercial conflicts that can arise when distributors serve dual roles.

How can Your FDA Approval Help with European Regulatory Requirements?

Your FDA submission contains valuable elements that support CE marking, reducing duplication and accelerating your European market entry. Several key components transfer effectively between regulatory systems:

  • Clinical data: Clinical studies conducted for FDA approval can contribute to your European clinical evaluation, potentially reducing the need for additional testing
  • Design documentation: Design verification and validation records demonstrate your device works as intended, satisfying similar European requirements
  • Quality management systems: Your ISO 13485-compliant QMS established for FDA purposes meets European requirements with minimal adjustment
  • Risk management files: Documentation following ISO 14971 applies across both markets with the same fundamental approach
  • Testing records: Manufacturing process validation, software verification records, and biocompatibility testing results transfer directly to European technical files

These transferable elements provide a strong foundation for your European submission, potentially reducing your market entry timeline by several months compared to starting from scratch. However, you’ll need Europe-specific additions to complete your conformity assessment.

Required European additions include conformity assessment procedures aligned with MDR requirements, essential requirements checklists demonstrating compliance with each applicable provision, and post-market surveillance systems meeting European expectations. Your labeling and instructions for use must meet European standards, including multiple language requirements and specific symbol usage. Clinical evaluation reports follow a different format than FDA clinical summaries, requiring synthesis of all available data rather than just your studies. The key is recognizing what transfers and what requires new work. Strategic planning helps you maximize your existing FDA investment while efficiently addressing Europe’s unique requirements.

How MedEnvoy Global Helps with European Medical Device Market Entry

MedEnvoy Global provides comprehensive support for manufacturers navigating the transition from FDA approval to European market access. Our services address the specific challenges of multi-market regulatory compliance:

  • EU Authorized Representative services: We serve as your dedicated regulatory contact point in Europe, handling communications with authorities and ensuring compliance with MDR requirements
  • Technical documentation review: Our team evaluates your existing FDA submission materials and identifies which elements transfer to your CE marking process, maximizing efficiency and reducing duplication
  • Gap analysis and planning: We conduct detailed assessments of Europe-specific requirements your FDA documentation doesn’t address, creating clear roadmaps for completing your conformity assessment
  • Multi-market coordination: We consolidate representation across European markets including the EU, UK, and Switzerland, simplifying your compliance management with a single point of contact
  • Independent regulatory focus: Unlike distributors who may face commercial conflicts, our exclusive focus on regulatory affairs ensures your compliance obligations receive dedicated attention

Understanding that FDA approval and CE marking are separate processes helps you plan realistic timelines and budgets for international medical device compliance. While the systems differ, your FDA work provides valuable building blocks for European market access. Contact MedEnvoy Global today to discuss how we can streamline your European regulatory pathway and accelerate your market entry while you maintain focus on innovation and growth.

Related Articles